Purpose: We evaluate the durable effect of high-energy transurethral microw
ave thermotherapy and transurethral prostatic resection for treatment of pa
tients with lower urinary tract symptoms suggestive of bladder outflow obst
ruction.
Materials and Methods: Between January 1996 and March 1997, 155 patients wi
th lower urinary tract symptoms suggestive of bladder outflow obstruction w
ere randomized to receive transurethral microwave thermotherapy (Prostatron
* device and commercial software) (82) or undergo transurethral prostatic r
esection (73). Initial patient evaluation was performed according to intern
ational standards. Patients were followed annually with the International P
rostate Symptom Score (I-PSS) and uroflowmetry (maximum flow rate). The Kap
lan-Meier survival analysis was used to calculate the cumulative risk of re
-treatment, adjusted for loss to followup.
Results: A total of 78 patients received transurethral microwave thermother
apy and 66 underwent transurethral prostatic resection. Median followup was
33 months. In the thermotherapy group mean maximum urinary flow rate impro
ved from 9.2 ml. per second at baseline to 15.1, 14.5 and 11.9 ml. per seco
nd at 1, 2 and 3 years, and mean I-PSS decreased from 20 to 8, 9, and 12, r
espectively. In the resection group the corresponding numbers for maximum u
rinary flow rate were 7.8, 24.5, 23.0 and 24.7 ml. per second at 1, 2 and 3
years, and for I-PSS were 20, 3, 4 and 3, respectively. At 36 months, 14 p
atients in the thermotherapy and 8 from the resection groups underwent re-t
reatment, and the cumulative risk was 19.8% (95% confidence interval 10.4%,
to 29.3% and 12.9% (4.5% to 21.3%), respectively (p = 0.28).
Conclusions: Transurethral microwave thermotherapy and transurethral prosta
tic resection achieve durable improvement in patients with lower urinary tr
act symptoms suggestive of bladder outflow obstruction, while the magnitude
of improvement is higher with resection. The repeat thermotherapy is based
on failure of therapy whereas repeat resection is based on complications o
f therapy.